Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Kirgan Danielle L.EVP, Chief HR Officer | Option exercise | M | — 8,539 sh | Mar 26, 2026 |
| 9 | Hancock MarkDirector, Co Fndr; Int CFO; Exec V Chair, 10% Owner | Grant or award | A | — 98.2K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 8 | Raben DavidChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $104K 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 8 | Bowe Patrick E.Director | Open-market sale · 10b5-1 plan | SELL | $58K 800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 8 | Low RussellDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $112K 1,244 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 6 | Owens Bradley D.General Counsel | Option exercise · 10b5-1 plan | M | $197K 8,800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 5 | Nithrakashyap ArvindDirector, Chief Technology Officer | Option exercise | M | — 40.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 5 | Nithrakashyap ArvindDirector, Chief Technology Officer | Option exercise | M | — 40.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 5 | Nithrakashyap ArvindDirector, Chief Technology Officer | Derivative conversion | C | — 40.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 4 | Misra AmitabhChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $243K 41.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 3 | Balcom AlexandraChief Financial Officer | Option exercise · 10b5-1 plan | M | $12K 11.4K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 3 | Samuelson Errol GChief Industry Dev. Officer | Grant or award · 10b5-1 plan | A | — 7,912 sh | Mar 26, 2026 traded Mar 26, 2026 |
| 3 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 3 | Balcom AlexandraChief Financial Officer | Option exercise · 10b5-1 plan | M | — 11.4K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Choudary Kiran KumarChief Financial Officer | Option exercise | M | — 212.2K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Soteropoulos PaulaDirector | Option exercise · 10b5-1 plan | M | $233K 27.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Choudary Kiran KumarChief Financial Officer | Derivative conversion | C | — 212.2K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Choudary Kiran KumarChief Financial Officer | Option exercise | M | — 7,188 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 2 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Raben DavidChief Medical Officer | Option exercise · 10b5-1 plan | M | $21K 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 0 | Chutter Jessica CarolineDirector | Grant or award · 10b5-1 plan | A | — 2,896 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Raben DavidChief Medical Officer | Option exercise · 10b5-1 plan | M | — 5,500 sh | Mar 26, 2026 traded Mar 25, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Mar 26, 2026 traded Mar 26, 2026 |
| 0 | Soteropoulos PaulaDirector | Option exercise · 10b5-1 plan | M | — 27.6K sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Chutter Jessica CarolineDirector | Grant or award · 10b5-1 plan | A | — 3,475 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 0 | Chutter Jessica CarolineDirector | Grant or award · 10b5-1 plan | A | — 4,000 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Owens Bradley D.General Counsel | Option exercise · 10b5-1 plan | M | — 8,800 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Mar 26, 2026 traded Mar 25, 2026 |
| 56 | Menell Richard PeterDirector | Open-market purchase | BUY | $29K 2,500 sh | Mar 25, 2026 traded Mar 24, 2026 |
| 50 | Angotti Vincent J.Director, CHIEF EXECUTIVE OFFICER | Open-market purchase | BUY | $125K 213.3K sh | Mar 25, 2026 traded Mar 13, 2026 |
| 47 | Angel MatthewDirector, CEO and President, 10% Owner | Open-market purchase | BUY | $500K 231.5K sh | Mar 25, 2026 traded Mar 24, 2026 |
| 44 | Armstrong Courtney DDirector | Open-market purchase | BUY | $3,980 16 sh | Mar 25, 2026 traded Nov 25, 2025 |
| 44 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $1.03M 12.6K sh | Mar 25, 2026 traded Mar 23, 2026 |
| 43 | Keyter CharlDirector, Chief Financial Officer | Open-market purchase | BUY | $95K 35.0K sh | Mar 25, 2026 traded Mar 23, 2026 |
| 42 | Parker Austin ColbyCFO and Treasurer | Open-market purchase | BUY | $36K 2,500 sh | Mar 25, 2026 traded Mar 25, 2026 |
| 41 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $634K 7,749 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $265K 3,162 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 41 | McBee BranninChief Development Officer | Open-market sale · 10b5-1 plan | SELL | $431K 5,140 sh | Mar 25, 2026 traded Mar 23, 2026 |